POLYGON AT ARMA LIVE! IN ANAHEIM

ARMA Live! Is the premier event for information professionals to connect, learn, and shape the profession. This year’s event will be held in Anaheim, California, from October 22-24, and Polygon will be on hand in Booth #724 to meet you and showcase our important services. About ARMA ARMA is a non-profit organization whose mission is…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Promoted Content · October 18, 2018 · Updated April 3, 2026Promoted Content

Key takeaways

Is the premier event for information professionals to connect, learn, and shape the profession.

This year’s event will be held in Anaheim, California, from October 22-24, and Polygon will be on hand in Booth #724 to meet you and showcase our important services.

About ARMA ARMA is a non-profit organization whose mission is…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

About ARMA

ARMA is a non-profit organization whose mission is to empower the community of information professionals to advance their careers, organizations, and the profession. In their ongoing efforts to be the driving force that enables organizations to harness the strategic power of information, each year they host ARMA Live!–a powerful event dedicated to the critical industry of information professionals.

About Live!

Those who manage and secure data are key players in almost every organization, and ARMA strives to support those who manage this critical asset for their teams. This year’s ARMA theme is the power of I. Information is power, especially when managed and leveraged by highly trained and knowledgeable information professionals. ARMA Live! is a great opportunity to meet with other superheroes in the exploding field of information management.

Polygon’s Services

Polygon is thrilled to be participating in this year’s event. Our organization has dedicated document restoration facilities throughout the United States and offers the most advanced techniques for document recovery and complete media restoration. Our vacuum freeze-drying process is the most efficient and effective method for the drying of wet papers and other documents.

In addition, we utilize state-of-art recovery and protection services in desiccant air drying, cleaning and sterilization, and digital imaging. Our complete offerings include paper, books, blueprints, X-rays, film restoration, copying, and scanning services. We invite you to stop by Booth #724 in Anaheim to discover more about these processes.

To learn more about the critical role of Polygon in supporting the information industry, visit us online today!

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

Book a Demo →Try it Free

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform

Media requests to your crowd, remote recording, AI writing tools

No demo required. No credit card.

For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Promoted Content

For Sciences teams

See how Sciences teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›

Keep exploring

More from Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512